Basic Information
| RNALocate ID: | RLID:11002581 |
| RNA Symbol: | hsa-miR-328-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-328 |
| RNA ID: | miRBase:MIMAT0000752 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002051 | Mitochondrion | HeLa cells | 27396686 |
| RLID:01002052 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:11002577 | Exosome | Serum | 18589210 |
| RLID:11002578 | Exosome | Peripheral blood mononuclear cells | 19002258 |
| RLID:11002579 | Exosome | Renal cancer cells | 21670082 |
| RLID:11002580 | Exosome | Brain tissue | 23382797 |
| RLID:11002582 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11002583 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000128 | Exosome | Blood | |
| RLID-D:11000429 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-328-3p | Diffuse large b cell lymphoma | MNDR-E-MI-40309 |
| MNDR | hsa-miR-328-3p | Oral squamous cell carcinoma | MNDR-E-MI-40310 |
| MNDR | hsa-miR-328-3p | Medulloblastoma | MNDR-E-MI-40311 |
| MNDR | hsa-miR-328-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-40312 |
| MNDR | hsa-miR-328-3p | Ovarian clear cell carcinoma | MNDR-E-MI-40313 |
| MNDR | hsa-miR-328-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-40314 |
| MNDR | hsa-miR-328-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-40315 |
| MNDR | hsa-miR-328-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-40316 |
| MNDR | hsa-miR-328-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-40317 |
| MNDR | hsa-miR-328-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-40318 |
| MNDR | hsa-miR-328-3p | Her2-receptor positive breast cancer | MNDR-E-MI-40319 |
| MNDR | hsa-miR-328-3p | Breast cancer luminal | MNDR-E-MI-40320 |
| MNDR | hsa-miR-328-3p | Dermatomyositis | MNDR-E-MI-40321 |
| MNDR | hsa-miR-328-3p | Prostate cancer | MNDR-E-MI-40322 |
| MNDR | hsa-miR-328-3p | Gastric cancer | MNDR-E-MI-40323 |
| MNDR | hsa-miR-328-3p | Alzheimer disease | MNDR-E-MI-40324 |
| MNDR | hsa-miR-328-3p | Intracranial aneurysm | MNDR-E-MI-40325 |
| MNDR | hsa-miR-328-3p | Bladder cancer | MNDR-E-MI-40326 |
| MNDR | hsa-miR-328-3p | Esophageal carcinoma | MNDR-E-MI-40327 |
| MNDR | hsa-miR-328-3p | Heart disease | MNDR-E-MI-40328 |
| MNDR | hsa-miR-328-3p | Dysautonomia familial | MNDR-E-MI-40329 |
| MNDR | hsa-miR-328-3p | Myotonic dystrophy | MNDR-E-MI-40330 |
| MNDR | hsa-miR-328-3p | Head and neck cancer | MNDR-E-MI-40331 |
| MNDR | hsa-miR-328-3p | Primary biliary cirrhosis | MNDR-E-MI-40332 |
| MNDR | hsa-miR-328-3p | Leukemia | MNDR-E-MI-40333 |
| MNDR | hsa-miR-328-3p | Huntington disease | MNDR-E-MI-40334 |
| MNDR | hsa-miR-328-3p | Chorea | MNDR-E-MI-40335 |
| MNDR | hsa-miR-328-3p | Lung cancer | MNDR-E-MI-40336 |
| MNDR | hsa-miR-328-3p | Parkinson disease | MNDR-E-MI-40337 |
| MNDR | hsa-miR-328-3p | Breast cancer | MNDR-E-MI-40338 |
| MNDR | hsa-miR-328-3p | Pancreatic cancer | MNDR-E-MI-40339 |
| MNDR | hsa-miR-328-3p | Melanoma | MNDR-E-MI-40340 |
| MNDR | hsa-miR-328-3p | Rectum adenocarcinoma | MNDR-E-MI-40341 |
| MNDR | hsa-miR-328-3p | Nephroblastoma | MNDR-E-MI-40342 |
| MNDR | hsa-miR-328-3p | Colon cancer | MNDR-E-MI-40343 |
| MNDR | hsa-miR-328-3p | Colon adenocarcinoma | MNDR-E-MI-40344 |
| MNDR | hsa-miR-328-3p | Multiple sclerosis | MNDR-E-MI-40345 |
| MNDR | hsa-miR-328-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-40346 |
| MNDR | hsa-miR-328-3p | Prostate adenocarcinoma | MNDR-E-MI-40347 |
| MNDR | hsa-miR-328-3p | Carcinoma ductal breast | MNDR-E-MI-40348 |
| MNDR | hsa-miR-328-3p | Glioblastoma | MNDR-E-MI-40349 |
| MNDR | hsa-miR-328-3p | Glioma | MNDR-E-MI-40350 |
| MNDR | hsa-miR-328-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-40351 |
| MNDR | hsa-miR-328-3p | Osteosarcoma | MNDR-E-MI-40352 |
| MNDR | hsa-miR-328-3p | Inclusion body myositis | MNDR-E-MI-40353 |
| MNDR | hsa-miR-328-3p | Infarction middle cerebral artery | MNDR-E-MI-40354 |
| MNDR | hsa-miR-328-3p | Liver cancer | MNDR-E-MI-40355 |
| MNDR | hsa-miR-328-3p | Uterine cancer | MNDR-E-MI-40356 |
| MNDR | hsa-miR-328-3p | Gastric adenocarcinoma | MNDR-E-MI-40357 |
| MNDR | hsa-miR-328-3p | Cervical squamous cell carcinoma | MNDR-E-MI-40358 |
| MNDR | hsa-miR-328-3p | Lung squamous cell carcinoma | MNDR-E-MI-40359 |
| MNDR | hsa-miR-328-3p | Carcinoma lung non-small-cell | MNDR-E-MI-40360 |
| MNDR | hsa-miR-328-3p | Lung adenocarcinoma | MNDR-E-MI-40361 |
| MNDR | hsa-miR-328-3p | Thyroid carcinoma | MNDR-E-MI-40362 |
| MNDR | hsa-miR-328-3p | Ovarian carcinoma | MNDR-E-MI-40363 |
| MNDR | hsa-miR-328-3p | Bladder urothelial carcinoma | MNDR-E-MI-40364 |
| MNDR | hsa-miR-328-3p | Pancreatic adenocarcinoma | MNDR-E-MI-40365 |
| MNDR | hsa-miR-328-3p | Carcinoma renal cell | MNDR-E-MI-40366 |
| MNDR | hsa-miR-328-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-40367 |
| MNDR | hsa-miR-328-3p | Renal clear cell carcinoma | MNDR-E-MI-40368 |
| MNDR | hsa-miR-328-3p | Cholangiocarcinoma | MNDR-E-MI-40369 |
| MNDR | hsa-miR-328-3p | Esophageal cancer | MNDR-E-MI-40370 |
| MNDR | hsa-miR-328-3p | Lung small cell carcinoma | MNDR-E-MI-40371 |
| MNDR | hsa-miR-328-3p | Breast invasive carcinoma | MNDR-E-MI-40372 |
| MNDR | hsa-miR-328-3p | Hepatocellular carcinoma | MNDR-E-MI-40373 |
| MNDR | hsa-miR-328-3p | Rheumatoid arthritis | MNDR-E-MI-40374 |
| MNDR | hsa-miR-328-3p | Retinoblastoma | MNDR-E-MI-40375 |
| MNDR | hsa-miR-328-3p | Barrett's adenocarcinoma | MNDR-E-MI-40376 |
| MNDR | hsa-miR-328-3p | Hodgkin disease | MNDR-E-MI-40377 |
| MNDR | hsa-miR-328-3p | Burkitt lymphoma | MNDR-E-MI-40378 |
| MNDR | hsa-miR-328-3p | Neuromyelitis optica | MNDR-E-MI-40379 |
| MNDR | hsa-miR-328-3p | Acute myeloid leukemia | MNDR-E-MI-40380 |
| MNDR | hsa-miR-328-3p | Colorectal cancer | MNDR-E-MI-40381 |
| MNDR | hsa-miR-328-3p | Ependymoma | MNDR-E-MI-40382 |
| MNDR | hsa-miR-328-3p | Prostatic neoplasms | MNDR-E-MI-40383 |
| MNDR | hsa-miR-328-3p | Barrett's carcinogenesis | MNDR-E-MI-40384 |
| MNDR | hsa-miR-328-3p | Breast cancer her3+ negative | MNDR-E-MI-40385 |
| MNDR | hsa-miR-328-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-40386 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCG2 | Homo sapiens | RR00024748 |
TOP